OVID
Ovid Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$461.00M
P/E Ratio
—
EPS
$-0.21
Beta
0.18
52W High
$3.10
52W Low
$0.27
50-Day MA
$2.57
200-Day MA
$1.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.79
PEG Ratio
0.00
About Ovid Therapeutics Inc
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $7.12M |
| Gross Profit (TTM) | $7.12M |
| EBITDA | $-47.57M |
| Operating Margin | -670.00% |
| Return on Equity | -18.80% |
| Return on Assets | -19.40% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $1.00 |
| Price-to-Book | 2.32 |
| Price-to-Sales (TTM) | 64.73 |
| EV/Revenue | 44.6 |
| EV/EBITDA | -0.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 845.00% |
| Shares Outstanding | $186.64M |
| Float | $161.29M |
| % Insiders | 6.99% |
| % Institutions | 56.43% |
Historical Volatility
HV 10-Day
58.01%
HV 20-Day
52.07%
HV 30-Day
56.29%
HV 60-Day
78.12%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($5.47 target)
10
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026